Susan Hasty, Publisher
Table of Contents . . . March 4th, 1996Non-Subscriber - Summaries Only
Vascular Disease - Adenoviral Vectors Damage Normal Arteries: Use Cautioned
Vectors (Alternative) - Fusogenic Liposome Efficiently Transduces Mammalian Cells
Vectors (Design) - Method Constructs Recombinant Adenoviruses Efficiently
Antisense Oligonucleotides (HBV) - Inhibition of HBV Gene Expression Reduces Hepatocellular Carcinoma In Vivo
Cancer Gene Therapy - Adoptive Antitumor Effect Via Engineered Cytotoxic T Lymphocytes
Conference Coverage (NCVDG) - UN AIDS Chief: HIV Vaccine Risks are "Ethically Valid"
Conference Coverage (NCVDG) - Unpredictable Evolutionary Leaps Possible for HIV
Conference Coverage (NCVDG) - Vaccine Seen As Only Answer To AIDS Epidemic
Gene Discovery - Researchers Find Altered Gene in Different Types of Common Cancers
Industry News (Joint Venture) - Companies Join To Develop Gene Transfer/Stem Cell Technologies
Industry News (Joint Venture) - Cystic Fibrosis Family Support Programs To Be Studied
Industry News (Joint Venture) - DNA Chip Agreement Signed for Gene Expression Monitoring
Industry News (Patents and Technology) - U.S. Patent Announced on Packaging Cell Line Used in Gene Therapy
Drug Development (HCV) - "Specific Inhibition of Hepatitis C Virus Core Antigen Production by Antisense RNA Constructs."
Antisense Technology - "Antisense Strategies and Therapeutic Applications."
Hematopoietic Stem Cells - "Retroviral Transfer of the Recombinant Human Erythropoietin Receptor Gene into Single Hematopoietic Stem Progenitor Cells from Human Cord Blood Increases the Number of Erythropoietin-Dependent Erythroid Colonies."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.